Market Report, "Metastatic Renal Cell Cancer - Pipeline Review, H1 2013", Published
Global Markets Direct's, 'Metastatic Renal Cell Cancer - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Metastatic Renal Cell Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Metastatic Renal Cell Cancer. Metastatic Renal Cell Cancer - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's...
View full press release